Surface engineering of gold nanoparticles for in vitro siRNA delivery.

Cellular uptake, endosomal/lysosomal escape, and the effective dissociation from the carrier are a series of hurdles for specific genes to be delivered both in vitro and in vivo. To construct siRNA delivery systems, poly(allylamine hydrochloride) (PAH) and siRNA were alternately assembled on the surface of 11.8 ± 0.9 nm Au nanoparticles (GNP), stabilized by denatured bovine serum albumin, by the ionic layer-by-layer (LbL) self-assembly method. By manipulating the outmost PAH layer, GNP-PAH vectors with different surface electric potentials were prepared. Then, the surface potential-dependent cytotoxicity of the resultant GNP-PAH particles was evaluated via sulforhodamine B (SRB) assay, while the surface potential-dependent cellular uptake efficiency was quantitatively analyzed by using the flow cytometry method based on carboxyfluorescein (FAM)-labeled siRNA. It was revealed that the GNP-PAH particles with surface potential of +25 mV exhibited the optimal cellular uptake efficiency and cytotoxicity for human breast cancer MCF-7 cells. Following these results, two more positively charged polyelectrolytes with different protonating abilities in comparison with PAH, i.e., polyethylenimine (PEI), and poly(diallyl dimethyl ammonium chloride) (PDDA), were chosen to fabricate similarly structured vectors. Confocal fluorescence microscopy studies indicated that siRNA delivered by GNP-PAH and GNP-PEI systems was better released than that delivered by the GNP-PDDA system. Further flow cytometric assays based on immunofluorescence staining of the epidermal growth factor receptor (EGFR) revealed that EGFR siRNA delivered by GNP-PAH and GNP-PEI exhibited similar down-regulation effects on EGFR expression in MCF-7 cells. The following dual fluorescence flow cytometry assays by co-staining phosphatidylserine and DNA suggested the EGFR siRNA delivered by GNP-PAH exhibited an improved silencing effect in comparison with that delivered by the commercial transfection reagent Lipofectamine 2000.

[1]  W. Weiss,et al.  RNA interference against a glioma-derived allele of EGFR induces blockade at G2M , 2005, Oncogene.

[2]  R. Langer,et al.  Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesis , 2005, The journal of gene medicine.

[3]  Vincent M Rotello,et al.  Efficient gene delivery vectors by tuning the surface charge density of amino acid-functionalized gold nanoparticles. , 2008, ACS nano.

[4]  Vincent M Rotello,et al.  Gold nanoparticles in delivery applications. , 2008, Advanced drug delivery reviews.

[5]  D. Astruc,et al.  Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. , 2004, Chemical reviews.

[6]  H. Tseng,et al.  Selective inhibition of human brain tumor cells through multifunctional quantum-dot-based siRNA delivery. , 2010, Angewandte Chemie.

[7]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Jin-Zhi Du,et al.  Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery. , 2010, Small.

[9]  Qiao Jiang,et al.  Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte. , 2010, ACS nano.

[10]  Zhiyong Tang,et al.  Reversible photoswitchable fluorescence in thin films of inorganic nanoparticle and polyoxometalate assemblies. , 2010, Journal of the American Chemical Society.

[11]  Shuming Nie,et al.  Cell-penetrating quantum dots based on multivalent and endosome-disrupting surface coatings. , 2007, Journal of the American Chemical Society.

[12]  J. Milner,et al.  Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference , 2002, Oncogene.

[13]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[14]  Takeshi Ono,et al.  Small interfering RNA targeting epidermal growth factor receptor enhances chemosensitivity to cisplatin, 5‐fluorouracil and docetaxel in head and neck squamous cell carcinoma , 2006, Cancer science.

[15]  Kanyawim Kirtikara,et al.  Sulforhodamine B colorimetric assay for cytotoxicity screening , 2006, Nature Protocols.

[16]  D. Sah.  Therapeutic potential of RNA interference for neurological disorders. , 2006, Life sciences.

[17]  Chad A Mirkin,et al.  Gold nanoparticles for biology and medicine. , 2010, Angewandte Chemie.

[18]  Xinrui Duan,et al.  Quantum dot-antisense oligonucleotide conjugates for multifunctional gene transfection, mRNA regulation, and tracking of biological processes. , 2011, Biomaterials.

[19]  Shuming Nie,et al.  Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging. , 2008, Journal of the American Chemical Society.

[20]  R. Nicholson,et al.  EGFR and cancer prognosis. , 2001, European journal of cancer.

[21]  R. Nicholson,et al.  Growth factor receptor interplay and resistance in cancer. , 2006, Endocrine-related cancer.

[22]  M. Gao,et al.  White‐light electroluminescence from self‐assembled Q‐CdSe/PPV multilayer structures , 1997 .

[23]  Jinwoo Cheon,et al.  All-in-one target-cell-specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery. , 2009, Angewandte Chemie.

[24]  Min Zhang,et al.  Inhibition of epidermal growth factor receptor expression by RNA interference in A549 cells. , 2004, Acta pharmacologica Sinica.

[25]  Luigi Naldini,et al.  Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics , 2001, Nature Medicine.

[26]  Z. Tang,et al.  Detection of mixed organophosphorus pesticides in real samples using quantum dots/bi-enzyme assembly multilayers , 2011 .

[27]  Chad A. Mirkin,et al.  Gene regulation with polyvalent siRNA-nanoparticle conjugates. , 2009, Journal of the American Chemical Society.

[28]  W. Walther,et al.  Viral Vectors for Gene Transfer , 2012, Drugs.

[29]  H. Jiang,et al.  Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo , 2006, Cancer Gene Therapy.

[30]  Qiang Wang,et al.  Luminescent properties of water-soluble denatured bovine serum albumin-coated CdTe quantum dots. , 2006, The journal of physical chemistry. B.

[31]  Mark E. Davis,et al.  Non-viral gene delivery systems. , 2002, Current opinion in biotechnology.

[32]  T. Park,et al.  siRNA delivery systems for cancer treatment. , 2009, Advanced drug delivery reviews.

[33]  Helmuth Möhwald,et al.  Electroluminescence Studies on Self-Assembled Films of PPV and CdSe Nanoparticles , 1998 .

[34]  Achim Goepferich,et al.  Layer-by-layer assembled gold nanoparticles for siRNA delivery. , 2009, Nano letters.

[35]  Robert Langer,et al.  Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery. , 2009, Nano letters.

[36]  P. Jain,et al.  Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. , 2007, Nanomedicine.

[37]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[38]  Keishiro Tomoda,et al.  Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. , 2008, Colloids and surfaces. B, Biointerfaces.

[39]  Yan Gao,et al.  Reversible plasmonic circular dichroism of Au nanorod and DNA assemblies. , 2012, Journal of the American Chemical Society.

[40]  Matthias John,et al.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs , 2004, Nature.

[41]  G. Hannon.  RNA interference : RNA , 2002 .

[42]  C. Murphy,et al.  Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. , 2005, Small.